Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-03-12 | Susan Hockfield, Ph.D. AGE: 70 DIRECTOR SINCE: 2020 BOARD COMMITTEES: Regulatory and Compliance and Science and Technology Professor of Neuroscience and President Emerita at the Massachusetts Institute of Technology (MIT). Served as MIT’s sixteenth president from 2004 to 2012. Member, Koch Institute for Integrative Cancer Research at MIT. Prior to joining MIT, she was the William Edward Gilbert Professor of Neurobiology, Dean of the Graduate School of Arts and Sciences from 1998 to 2002 and Provost from 2003 to 2004 at Yale University. Served as Science Envoy with the U.S. Department of State and as a member of a Congressional Commission evaluating the Department of Energy laboratories. Founding co-chair of the Advanced Manufacturing Partnership. Member of the American Academy of Arts and Sciences and the Society for Neuroscience. Recipient of the Charles Judson Herrick Award from the American Association of Anatomists, the Wilbur Lucius Cross Award from Yale University, the Meliora Citation from the University of Rochester, the Golden Plate Award from the Academy of Achievement, the Amelia Earhart Award from the Women’s Union, the Edison Achievement Award, the Pinnacle Award for Lifetime Achievement from the Greater Boston Chamber of Commerce and the Geoffrey Beene Builders of Science Award from Research!America. She previously served as a Director of General Electric Company from 2006 until 2018 and a Director of Qualcomm from 2012 until 2016. KEY SKILLS & EXPERIENCE: Academia/Business Leadership & Operations/Medicine & Science: Dr. Hockfield has strong leadership skills, having served as the first woman and first life scientist President of MIT from 2004 to 2012 and as Dean of the Graduate School of Arts and Sciences from 1998 to 2002 and Provost from 2003 to 2004 at Yale University. Her background also reflects significant achievements in academia and science as she has served as a professor of Neuroscience at MIT since 2004. Pfizer benefits from her experience, expertise, achievements and recognition in both medicine and science. Government & Public Policy: Pfizer also benefits from Dr. Hockfield’s breadth and depth of experience in the public policy space, which includes her public service as Science Envoy with the U.S. Department of State, co-chair of the Advanced Manufacturing Partnership, as a member of a Congressional Commission evaluating the Department of Energy laboratories, and as President-elect, President, and Chair of the American Association for the Advancement of Science. |
| 2022-03-17 | Director Nominees: Susan Hockfield, Ph.D. - Academia/Business Leadership & Operations. |
| 2023-03-16 | Susan Hockfield, Ph.D., Age: 72, Director Since: 2020, Board Committees: Regulatory and Compliance and Science and Technology, Total Compensation: $358,698 |
| 2024-03-14 | Susan Hockfield, Ph.D. Age: 73 Director Since: 2020 Board Committees: Regulatory and Compliance and Science and Technology 2023 Director Compensation Table: Fees Earned or Paid in Cash ($) 155,000, Stock Awards ($) 205,000, All Other Compensation ($) 3,000, Total ($) 363,000 |
| 2025-03-13 | Susan Hockfield, Ph.D. Age: 74 Director Since: 2020 Board Committees: Regulatory and Compliance and Science and Technology 2024 Director Compensation Table: Fees Earned or Paid in Cash: 155,000, Stock Awards: 205,000, Total: 363,000 |
Data sourced from SEC filings. Last updated: 2025-07-01